22,757 Shares in Colgate-Palmolive Company $CL Bought by Reliant Investment Management LLC

Posted by Stanley Muller on Oct 15th, 2026

Reliant Investment Management LLC bought a new position in Colgate-Palmolive Company (NYSE:CL – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 22,757 shares of the company’s stock, valued at approximately $1,942,000.

A number of other large investors have also added to or reduced their stakes in the stock. Godsey & Gibb Inc. purchased a new position in shares of Colgate-Palmolive in the 3rd quarter worth $5,777,000. Columbus Macro LLC increased its position in Colgate-Palmolive by 18.2% during the third quarter. Columbus Macro LLC now owns 139,078 shares of the company’s stock valued at $11,866,000 after acquiring an additional 21,427 shares during the last quarter. Union Savings Bank increased its position in Colgate-Palmolive by 1,886.8% during the third quarter. Union Savings Bank now owns 3,457 shares of the company’s stock valued at $295,000 after acquiring an additional 3,283 shares during the last quarter. Essex LLC lifted its holdings in Colgate-Palmolive by 32.8% in the third quarter. Essex LLC now owns 3,518 shares of the company’s stock valued at $300,000 after acquiring an additional 868 shares during the period. Finally, Triumph Capital Management lifted its holdings in Colgate-Palmolive by 93.8% in the third quarter. Triumph Capital Management now owns 901 shares of the company’s stock valued at $77,000 after acquiring an additional 436 shares during the period. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 3.2%

CL stock opened at $92.80 on Thursday. The business’s 50-day moving average price is $89.04 and its 200-day moving average price is $88.93. The stock has a market cap of $73.98 billion, a P/E ratio of 36.83, a PEG ratio of 4.30 and a beta of 0.33. The company has a quick ratio of 0.67, a current ratio of 1.03 and a debt-to-equity ratio of 13.82. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $99.33.

Colgate-Palmolive (NYSE:CL – Get Free Report) last released its earnings results on Friday, July 31st. The company reported $0.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.95 by $0.04. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The company had revenue of $5.36 billion during the quarter, compared to analyst estimates of $5.36 billion. During the same period in the prior year, the firm posted $0.92 EPS. The firm’s quarterly revenue was up 4.9% compared to the same quarter last year. On average, equities research analysts forecast that Colgate-Palmolive Company will post 3.87 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th will be given a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Tuesday, October 20th. Colgate-Palmolive’s dividend payout ratio is presently 84.13%.

Insider Transactions at Colgate-Palmolive

In related news, Director John T. Cahill sold 4,170 shares of Colgate-Palmolive stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $93.37, for a total transaction of $389,352.90. Following the transaction, the director owned 28,373 shares in the company, valued at approximately $2,649,187.01. The trade was a 12.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Noel R. Wallace sold 161,021 shares of the company’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $91.92, for a total transaction of $14,801,050.32. Following the completion of the transaction, the chief executive officer directly owned 362,231 shares of the company’s stock, valued at $33,296,273.52. This represents a 30.77% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 175,191 shares of company stock valued at $16,110,903 over the last three months. Corporate insiders own 0.43% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have commented on CL shares. UBS Group upped their target price on shares of Colgate-Palmolive from $106.00 to $109.00 and gave the company a “buy” rating in a report on Monday, August 3rd. Bank of America dropped their price target on shares of Colgate-Palmolive from $102.00 to $100.00 and set a “buy” rating on the stock in a research note on Friday, October 9th. Evercore boosted their price objective on shares of Colgate-Palmolive from $100.00 to $101.00 and gave the company an “outperform” rating in a research report on Thursday, October 8th. Jefferies Financial Group restated a “hold” rating and issued a $89.00 price objective (up from $88.00) on shares of Colgate-Palmolive in a research note on Monday, August 3rd. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $101.00 price objective (up from $99.00) on shares of Colgate-Palmolive in a research note on Monday, August 3rd. Thirteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, Colgate-Palmolive has a consensus rating of “Moderate Buy” and a consensus target price of $98.11.

Get Our Latest Analysis on CL

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.

The company markets many of its products under well-known brands, including Colgate, Palmolive, elmex, meridol, Protex, Softsoap, Ajax, Irish Spring, Speed Stick, Tom’s of Maine and Hill’s Science Diet.